Anthony Doyle is Chief Financial Officer of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 259,628 shares of BCRX, which is worth approximately $1.97 Million. The most recent transaction as insider was on Dec 14, 2024, when has been sold 7,890 shares (Common Stock) at a price of $7.53 per share, resulting in proceeds of $59,411. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 260K
2.67% 3M change
14.15% 12M change
Total Value Held $1.97 Million

Anthony Doyle Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2024
SELL
Payment of exercise price or tax liability
$59,411 $7.53 p/Share
7,890 Reduced 2.95%
259,628 Common Stock
May 14 2024
BUY
Open market or private purchase
$202,191 $5.57 p/Share
36,300 Added 11.98%
266,744 Common Stock
Dec 19 2023
SELL
Payment of exercise price or tax liability
$15,016 $6.05 p/Share
2,482 Reduced 1.08%
227,444 Common Stock
Dec 14 2023
SELL
Payment of exercise price or tax liability
$35,204 $6.43 p/Share
5,475 Reduced 2.33%
229,926 Common Stock
Dec 14 2023
BUY
Grant, award, or other acquisition
-
34,000 Added 12.62%
235,401 Common Stock
Dec 19 2022
BUY
Grant, award, or other acquisition
-
34,000 Added 14.66%
197,966 Common Stock
Dec 15 2022
SELL
Open market or private sale
$62,130 $10.9 p/Share
5,700 Reduced 3.36%
163,966 Common Stock
Dec 14 2021
BUY
Grant, award, or other acquisition
-
115,000 Added 35.52%
208,719 Common Stock
Nov 23 2021
BUY
Open market or private purchase
$440,020 $12.48 p/Share
35,258 Added 27.34%
93,719 Common Stock
AD

Anthony Doyle

Chief Financial Officer
Durham, NC

Track Institutional and Insider Activities on BCRX

Follow BIOCRYST PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Track Activities on BCRX